Applying Sensor‐Based Technology to Optimize Blood Glucose Time-in-Range (TIR), Health Metrics Across the Comprehensive Spectrum of Diabetes Care: Establishing a New, Guideline- and Evidence-Based Standard of Care for Persons with Diabetes
Applying Sensor-Based Glucose Monitoring and Telemedicine to Optimize Real World Impact and Diabetes Management in the Age of Covid-19—What Have the Studies Taught Us? How Do We Apply Them to Diabetes Practice Now?
A Practical Roadmap for Using Registry Data and Trial-Based Evidence to Guide Use of Sensor‐Based, Glucose Monitoring: Focus on Results from the Swedish National Diabetes Register (NDR) to Optimize Multi-Dose Insulin (MDI) Therapy in Persons with Diabetes
Translating Guidelines and Meta‐Analysis Trials to Guide Practical Aspects of Diabetes Care: Using Sensor-Based Glucose Monitoring to Improve Time in Range (TIR) for Persons with Diabetes on Non-Insulin Regimens
The Foundational Role of Sensor‐Based Glucose Monitoring Technology—How Should Clinicians and Patients Collaborate to Maximize Blood Glucose Time in Range and Improve Safety and Health Outcomes in Persons with Diabetes?